归创通桥(02190)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02190 归创通桥

已收盘 04-28 16:08:26

22.600

-0.540

-2.33%

最高23.140	最低22.300	成交量58.01万
今开22.320	昨收23.140	日振幅3.63%
总市值75.71亿	流通市值74.13亿	总股本3.35亿
成交额1,314万	换手率0.18%	流通股本3.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02190","market":"HK","secType":"STK","nameCN":"归创通桥","latestPrice":22.6,"timestamp":1777363706003,"preClose":23.14,"halted":0,"volume":580138,"delay":0,"changeRate":-0.023336214347450264,"floatShares":328000000,"shares":335000000,"eps":0.8653621801200384,"marketStatus":"已收盘","change":-0.54,"latestTime":"04-28 16:08:26","open":22.32,"high":23.14,"low":22.3,"amount":13142898,"amplitude":0.036301,"askPrice":22.6,"askSize":6500,"bidPrice":22.5,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":0.8653621801200384,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777426200000},"marketStatusCode":5,"adr":0,"listingDate":1625414400000,"exchange":"SEHK","adjPreClose":23.14,"dividendRate":0.011177,"openAndCloseTimeList":[[1777339800000,1777348800000],[1777352400000,1777363200000]],"volumeRatio":1.101668,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02190","defaultTab":"news","newsList":[{"id":"1197956991","title":"归创通桥：4月27日回购4.9万股，耗资约112.85万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197956991","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197956991?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:01","pubTimestamp":1777284110,"startTime":"0","endTime":"0","summary":"2026年4月27日，归创通桥医疗科技股份有限公司发布公告，披露了近期股份回购事宜。公司于当日在香港联交所场内回购4.9万股H股，占现有已发行股份约0.0146%。本次回购的价格区间为每股22.70港元至23.14港元，合计耗资约112.85万港元。根据公告，本次回购完成后，公司已发行股本总数维持在336,350,744股，其中327,704,113股为流通股，库藏股则增至8,646,631股。公司在公告中确认，其股份购回行为符合香港联交所上市规则以及相关法律法规要求。公告由公司董事赵中签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"归创通桥：4月27日回购4.9万股，耗资约112.85万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630021364","title":"归创通桥(02190)4月27日斥资112.85万港元回购4.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630021364","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630021364?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:54","pubTimestamp":1777283686,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，该公司于2026年4月27日斥资112.85万港元回购4.9万股股份，每股回购价格为22.7-23.14港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02190","BK1587","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629411348","title":"归创通桥(02190)4月24日斥资114.06万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629411348","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629411348?lang=zh_cn&edition=full","pubTime":"2026-04-24 20:47","pubTimestamp":1777034828,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年4月24日斥资114.06万港元回购5万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02190","BK1587","BK1583","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132433803","title":"归创通桥回购5万股股份，总额约114.06万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132433803","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132433803?lang=zh_cn&edition=full","pubTime":"2026-04-24 20:47","pubTimestamp":1777034825,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司  于2026年4月24日发布公告，披露近期在香港联交所场内进行了股份购回操作。公司于2026年4月24日回购普通股股份共计50,000股，占本次回购前已发行股本约0.0149%。根据公告，公司回购授权于2025年5月30日获股东大会通过，可回购股份总数为31,958,111股，截至目前累计回购5,778,000股，占授权通过当日已发行股本约1.7654%。公司在公告中确认，本次股份回购已获董事会正式批准，并遵守香港联交所主板上市规则及相关法律法规要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"归创通桥回购5万股股份，总额约114.06万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106184156","title":"归创通桥回购5万股股份，总金额约113.17万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106184156","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106184156?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:32","pubTimestamp":1776943939,"startTime":"0","endTime":"0","summary":"归创通桥于2026年4月23日发布公告，披露在香港联交所场内回购公司H股。本次回购股份数量为50,000股，约占该次回购前已发行股份总数的0.0149%。回购价格区间介乎每股22.42港元至23.22港元，总金额约113.17万港元。公告显示，回购授权于2025年5月30日通过，公司可根据该授权回购最多31,958,111股，迄今已回购5,728,000股，占授权通过当日已发行股份的1.7502%。公司在公告中确认，本次回购股份已获董事会正式批准并遵守所有适用上市规则及相关法规。公告由公司董事赵中签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"归创通桥回购5万股股份，总金额约113.17万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629716835","title":"归创通桥(02190)4月23日斥资113.17万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629716835","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629716835?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:31","pubTimestamp":1776943906,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年4月23日斥资113.17万港元回购5万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1100","BK1587","BK1583","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162459314","title":"归创通桥：4月22日回购4.85万股股份，耗资约112.46万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162459314","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162459314?lang=zh_cn&edition=full","pubTime":"2026-04-22 18:07","pubTimestamp":1776852460,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司于2026年4月22日公告称，公司当日于香港联交所场内回购股份48,500股，占已发行股本约0.0144%。每股回购价介乎23.12港元至23.30港元，合计支付约1,124,580港元。\\n\\n本次回购完成后，公司已发行股本为327,853,113股，库藏股数为8,497,631股，合计336,350,744股。公告显示，此次回购已获得公司于2025年5月30日通过的购回授权，授权总数为31,958,111股，截至目前公司累计回购5,678,000股。\\n\\n公司确认有关回购事项已遵守香港联交所证券上市规则及相关法例。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"归创通桥：4月22日回购4.85万股股份，耗资约112.46万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193921734","title":"归创通桥回购4.8万股股份，总额约111.67万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193921734","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193921734?lang=zh_cn&edition=full","pubTime":"2026-04-21 19:07","pubTimestamp":1776769627,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司于2026年4月21日公告，办理了股份回购事宜。本次回购在香港联交所场内进行，回购数量为4.8万股，占当日公司已发行股本约0.0143%。每股价格区间为23.02港元至23.48港元，总金额约111.67万港元。回购完成后，公司已发行股本变为327,901,613股，库藏股数量增至8,449,131股，总股本保持336,350,744股不变。公司回购授权于2025年5月30日获股东大会通过，初始授权可回购股份合计31,958,111股，至今累计已回购5,629,500股，占授权通过当天已发行股本约1.7201%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"归创通桥回购4.8万股股份，总额约111.67万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629033532","title":"归创通桥(02190)4月21日斥资111.67万港元回购4.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629033532","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629033532?lang=zh_cn&edition=full","pubTime":"2026-04-21 19:02","pubTimestamp":1776769349,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年4月21日该公司斥资111.67万港元回购4.8万股，回购价格为每股23.02-23.48港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431410.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","BK1100","BK1587","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193027447","title":"归创通桥将于2026年6月18日派发末期股息每股0.22元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193027447","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193027447?lang=zh_cn&edition=full","pubTime":"2026-04-21 17:32","pubTimestamp":1776763929,"startTime":"0","endTime":"0","summary":"根据公司最新公告显示，公司董事会决议宣派截至2025年12月31日止年度的末期股息，每股人民币0.22元，尚待于2026年5月13日获得股东批准。公司预计2026年5月27日为除净日，2026年5月28日16:30为递交股份过户文件的最后时限，2026年5月29日至6月2日暂停办理股份过户登记，6月2日为记录日期，股息派发日定于2026年6月18日。更新该公告的主要原因系调整股东批准日期，其他信息则保持不变。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114926437","title":"归创通桥授予董事H股购回授权，规模最高达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1114926437","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114926437?lang=zh_cn&edition=full","pubTime":"2026-04-21 17:16","pubTimestamp":1776762996,"startTime":"0","endTime":"0","summary":"归创通桥在港交所公告，董事会已提请于2026年5月13日召开的2025年股东周年大会上，寻求一般及无条件授权，最高可回购不超过公司已发行H股总数10%的股份。拟议中的回购授权有效期将自公司股东周年大会批准之日起，至下一年度股东周年大会结束时或经股东特别决议撤销或修订授权之日止。公司呼吁股东在指定日期出席会议，并就相关决议案进行投票表决。另据公告，若股东大会表决通过，回购操作将严格依照法律法规程序和香港上市规范执行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"归创通桥授予董事H股购回授权，规模最高达已发行股本一成","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629087757","title":"【券商聚焦】中信建投：医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087757","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629087757?lang=zh_cn&edition=full","pubTime":"2026-04-21 09:19","pubTimestamp":1776734371,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研究认为，医疗器械板块拐点已经来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979495","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00241","BK1593","BK1247","09996","06826","BK1584","BK1600","09997","LU0287142896.SGD","LU0173614495.USD","BK1502","BK1583","BK1610","BK1591","BK1161","BK1571","BK1515","BK0276","BK1617","BK1189","02252","BK1100","02235","BK1589","BK1615","BK1222","BK1501","BK1585","BK1587","601066","01302","159883","00853","BK1142","02190","BK1574","01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110607504","title":"归创通桥：2026年4月20日回购4.8万股股份，耗资约113.93万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110607504","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110607504?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:56","pubTimestamp":1776679018,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司于2026年4月20日发布公告称，公司当日在香港联交所场内回购48,000股H股，占现有已发行股份约0.0143%。回购价格介乎每股港币23.48元至24.10元，合计涉资约113.93万港元。本次回购后，公司已发行股份数量降至327,949,613股，库藏股数增至8,401,131股，整体股本总数仍为336,350,744股。公司于2025年5月30日获股东大会批准回购最多31,958,111股，公告显示此前已于市场累计回购5,581,500股，剩余可回购数量为26,376,611股。公司确认已遵守香港联交所上市规则及相关法例。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628499517","title":"归创通桥(02190)4月20日斥资113.93万港元回购4.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628499517","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628499517?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:55","pubTimestamp":1776678905,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年4月20日，该公司斥资113.93万港元回购4.8万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","02190","BK1574","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111644534","title":"归创通桥4月17日回购4.8万股，涉资约114.63万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111644534","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111644534?lang=zh_cn&edition=full","pubTime":"2026-04-17 18:53","pubTimestamp":1776423224,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司（股票代码02190）于2026年4月17日公告，4月17日在香港联交所场内回购了48,000股，占本次回购前已发行股本约0.0143%。每股回购价介乎每股23.54港元至24.06港元，总金额约114.63万港元。\n回购完成后，公司已发行股本变为327,997,613股，库藏股数量增至8,353,131股。根据公告，购回授权于2025年5月30日通过，授权购回总数为31,958,111股。截至目前，公司已累计回购5,533,500股，占授权通过日已发行股本1.6907%。公司确认，相关回购操作已遵守香港联交所上市规则及相关法律法规。\n本公告由公司董事赵中签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627290451","title":"归创通桥(02190)4月16日斥资114.54万港元回购4.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627290451","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627290451?lang=zh_cn&edition=full","pubTime":"2026-04-16 19:57","pubTimestamp":1776340621,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年4月16日，该公司斥资114.54万港元回购4.8万股股份，每股回购价23.6-24.24港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260416/32148928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02190","BK1587","BK1583","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182921338","title":"归创通桥回购4.8万股股份，总额约114.54万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182921338","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182921338?lang=zh_cn&edition=full","pubTime":"2026-04-16 19:42","pubTimestamp":1776339736,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司于2026年4月16日公告，回购公司合共48,000股H股，占当日已发行股本约0.0143%。此次回购价格介乎每股23.60港元至24.24港元，总涉资约114.54万港元。据公告显示，公司回购后已发行股本数为328,045,613股，库藏股数量为8,305,131股，总股份数仍为336,350,744股。此次回购依据2025年5月30日通过的购回授权，最高可回购31,958,111股。公司确认本次股份回购已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由公司董事赵中签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627766289","title":"归创通桥(02190)4月15日斥资296.25万港元回购12.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627766289","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627766289?lang=zh_cn&edition=full","pubTime":"2026-04-15 19:43","pubTimestamp":1776253405,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年4月15日斥资296.25万港元回购12.3万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","02190","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160758876","title":"归创通桥回购12.3万股股份，耗资约296.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160758876","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160758876?lang=zh_cn&edition=full","pubTime":"2026-04-15 19:42","pubTimestamp":1776253326,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司于2026年4月15日公告，披露在香港联交所场内回购股份事宜。本次合计回购12.3万股股份，占该公司现有已发行股本约0.0366%，每股回购价介乎港元23.18元至24.34元，涉资约296.25万港元。公司回购授权于2025年5月30日获得通过，可回购总数为31,958,111股，此前已回购5,437,500股。公司在公告中表示，上述交易已遵守相关上市规则及适用法规。公告由公司董事赵中签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115146145","title":"归创通桥于4月14日回购12.2万股，涉资约285.02万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115146145","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115146145?lang=zh_cn&edition=full","pubTime":"2026-04-14 19:26","pubTimestamp":1776165984,"startTime":"0","endTime":"0","summary":"归创通桥医疗科技股份有限公司于2026年4月14日公告，公司当日于香港联交所场内回购122,000股H股，占回购前已发行股本约0.0363%。回购价格介乎每股23.14港元至23.68港元，总金额2,850,160港元。根据此前于2025年5月30日通过的购回授权，公司可回购合计31,958,111股。截至目前，累计已回购5,314,500股，占授权通过当日已发行股本的1.6238%。公司在公告中确认，此次回购已遵守上市规则及相关法律规定。公告由公司董事赵中签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zyloxmedical.com","stockEarnings":[{"period":"1week","weight":-0.0187},{"period":"1month","weight":-0.0358},{"period":"3month","weight":-0.0707},{"period":"6month","weight":-0.043},{"period":"1year","weight":0.2526},{"period":"ytd","weight":0.0017}],"compareEarnings":[{"period":"1week","weight":-0.0165},{"period":"1month","weight":0.039},{"period":"3month","weight":-0.0443},{"period":"6month","weight":-0.016},{"period":"1year","weight":0.1795},{"period":"ytd","weight":0.0115}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"归创通桥医疗科技股份有限公司是一家主要从事为患者及医生提供涵盖神经血管介入器械及外周血管介入器械的产品组合解决方案的中国公司。神经血管介入产品主要包括“银蛇”颅内支持导管、“凤”颅内动脉瘤栓塞弹簧圈、“通桥麒麟”血流导向装置、“蛟龙”取栓支架以及“北斗SS”神经血管导丝等。外周血管介入产品主要包括“UltraFree”药物洗脱经皮腔内血管成形术（PTA）球囊扩张导管、“ZYLOX Octoplus”可回收腔静脉滤器、腔静脉滤器抓捕器及“ZYLOX Swan”静脉腔内射频闭合导管等。该公司主要在中国国内市场及德国、法国、意大利、土耳其等海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.038267},{"month":2,"riseRate":0.4,"avgChangeRate":-0.097164},{"month":3,"riseRate":0.6,"avgChangeRate":0.021512},{"month":4,"riseRate":0.6,"avgChangeRate":0.08799},{"month":5,"riseRate":0.5,"avgChangeRate":-0.029077},{"month":6,"riseRate":0.75,"avgChangeRate":0.088544},{"month":7,"riseRate":0.5,"avgChangeRate":-0.038763},{"month":8,"riseRate":0.4,"avgChangeRate":-0.049708},{"month":9,"riseRate":0.6,"avgChangeRate":0.019857},{"month":10,"riseRate":0.2,"avgChangeRate":-0.028854},{"month":11,"riseRate":0.6,"avgChangeRate":0.041084},{"month":12,"riseRate":0.6,"avgChangeRate":0.027438}],"exchange":"SEHK","name":"归创通桥","nameEN":"ZYLOXTB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"归创通桥(02190)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供归创通桥(02190)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"归创通桥,02190,归创通桥股票,归创通桥股票老虎,归创通桥股票老虎国际,归创通桥行情,归创通桥股票行情,归创通桥股价,归创通桥股市,归创通桥股票价格,归创通桥股票交易,归创通桥股票购买,归创通桥股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"归创通桥(02190)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供归创通桥(02190)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}